Therefore, elucidating the conceivable contribution of GSK3β to the interaction of PSCs and CAFs with tumor cells may provide a new strategy for targeting the tumor-promoting stroma, thereby combatting chemoresistance in pancreatic cancer. The gene discussed is GSK3B; the disease is pancreatic neoplasm.